Lexeo Therapeutics Inc (LXEO) Stock Price, Quote, News & History

LXEONASDAQ
$4.93
-0.05-1.00%
At close: Jun 18, 5:00 PM EST
$4.93
N/A
After Hours: Jun 18, 4:02 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-97.99M
Investing Cash Flow (TTM)
-78.39M
Financing Cash Flow (TTM)
219.24M
Free Cash Flow (TTM)
-98.42M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
42.86M

Analyst Trends and Forecast

2
Jan
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$200.65M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.69
Earnings Yield % (TTM)
-22.49%
Earnings Yield % (FWD)
-24.00%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.95

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$495.00K
Total Cash
$71.77M
Debt to Equity
0.03
Issuance of Debt (TTM)
-$495.00K
Repayment of Debt (TTM)
-$495.00K

Key Statistics

Open
$4.99
Close
$4.93
Volume / Avg.
1.48M / 865.81K
Day Range
$4.92 - $5.34
52 Wk Range
3.60 - 10.99
Market Cap
$387.11M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
51
Short Interest
20.62%
Days to Cover
17.36

About

Sector
Health Care
Industry
Biotechnology
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Lexeo Therapeutics (LXEO) stock?

A

You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lexeo Therapeutics (LXEO) competitors?

A

There are no as such competitors for Lexeo Therapeutics.

Q

What is the forecast, or price target, for Lexeo Therapeutics (LXEO) stock?

A

Lexeo Therapeutics has a consensus price target of $19.50.

Q

What is the current price for Lexeo Therapeutics (LXEO)?

A

The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $4.93 last updated June 18, 2026 at 4:02 PM EDT.

Q

Does Lexeo Therapeutics (LXEO) pay a dividend?

A

There are no upcoming dividends for Lexeo Therapeutics.

Q

When is Lexeo Therapeutics (NASDAQ:LXEO) reporting earnings?

A

Lexeo Therapeutics does not have any upcoming earnings scheduled.

Q

Is Lexeo Therapeutics (LXEO) going to split?

A

There is no upcoming split for Lexeo Therapeutics.

Q

What sector and industry does Lexeo Therapeutics (LXEO) operate in?

A

Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.